How parathyroid hormone affects fat metabolism in bones
Parathyroid hormone (PTH) modulates lipid metabolism in the skeletal niche
This study is looking at how a treatment called intermittent parathyroid hormone (iPTH) can help improve bone health by affecting fat cells in the bones, which could lead to better options for people with osteoporosis and osteopenia.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-10865113 on NIH RePORTER |
What this research studies
This research investigates the effects of intermittent parathyroid hormone (iPTH) on lipid metabolism within the skeletal system, particularly focusing on how it influences bone health. The study aims to understand how iPTH can promote bone formation by modulating fat cells in the bone marrow and enhancing the energy supply for bone-building cells. By exploring these mechanisms, the research seeks to develop better therapeutic options for conditions like osteoporosis and osteopenia, which affect millions of adults. Patients may benefit from insights that could lead to improved treatments with fewer side effects.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are at risk for or suffering from osteoporosis or osteopenia.
Not a fit: Patients who are younger than 21 or do not have any bone health issues may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for osteoporosis and related bone health issues.
How similar studies have performed: Other research has shown promising results in understanding the role of hormones in bone metabolism, suggesting that this approach could yield significant insights.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Rendina-Ruedy, Elizabeth — Vanderbilt University Medical Center
- Study coordinator: Rendina-Ruedy, Elizabeth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.